http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19634730-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2bab3cc63d1b7d76a19c166506a555f6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-4208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6879 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-109 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate | 1996-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0254b0f1b9dfabd2a792b3d1e386472 |
| publicationDate | 1998-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-19634730-A1 |
| titleOfInvention | New combination preparations and their use in immunodiagnostics and immunotherapy |
| abstract | Combination preparations (comprising bispecific antibodies (I)), useful for imaging, diagnosis and treatment comprise \- 1 first component with a specific, immunologically reactive determinant Ha1, and a bispecific second component with binding specificity for Ha1 (anti-Ha1) and \- 1 further binding specificity for a defined specific, immunologically reactive determinant H2 different from Ha1 (anti-Ha2) or with further binding specificities for several such determinants Han (anti-Han) which are different from one another and a third component which is or are provided with \- 1 defined specific, immunologically reactive determinant Ha2 or with several such determinants Han, where Ha11 (sic), Ha2 and Han are different from each other. Also claimed is an immunolinker comprising of a bispecific reagent Y with binding specificities for \- 2 different defined specific, immunologically reactive determinants, where Y represents a reagent bispecific for \- 2 determinants Hai (sic) and Ha2 or Han, comprising an inert particle, a protein, an immunoglobulin or an antibody, a diabody, with the corresponding anti-Ha1, anti-Ha2 or anti-Han specificities. Ha1 represents a defined specific, immunologically reactive determinant, comprising a hapten, a specifically couplable antigenic structure, an epitope, a paratope, an idiotope. Ha2 represents a defined specific, immunologically reactive determinant as above which is different from Ha1. Han represents any defined specific, immunologically reactive determinant other than Ha1 and Ha2. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8632994-B2 |
| priorityDate | 1996-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 869.